Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

1.39
+0.150012.10%
Volume:2.58M
Turnover:3.59M
Market Cap:177.45M
PE:-0.84
High:1.55
Open:1.24
Low:1.20
Close:1.24
Loading ...

Why Prime Medicine (PRME) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
31 Dec 2024

Prime Medicine, Inc. (PRME): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey
·
29 Dec 2024

Prime Medicine Files for Resale of 11 Million Shares

MT Newswires Live
·
13 Dec 2024

Prime Medicine Inc Files for Resale of up to 11 Mln Common Shares by the Selling Stockholder - SEC Filing

THOMSON REUTERS
·
13 Dec 2024

JMP Securities Initiates Prime Medicine at Market Outperform With $10 Price Target

MT Newswires Live
·
10 Dec 2024

Prime Medicine Price Target Maintained With a $18.00/Share by Guggenheim

Dow Jones
·
04 Dec 2024

Prime Medicine, Inc. (PRME) Gets a Hold from Morgan Stanley

TIPRANKS
·
15 Nov 2024

Prime Medicine Is Maintained at Buy by Chardan Capital

Dow Jones
·
14 Nov 2024

Prime Medicine, Inc.: Strategic Initiatives and Promising Developments Drive Buy Rating

TIPRANKS
·
13 Nov 2024

Prime Medicine Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Nov 2024

Prime Medicine, Inc. Receives Buy Rating from Arthur He CFA: Strategic Partnerships and Pipeline Focus Drive Promising Future Prospects

TIPRANKS
·
13 Nov 2024

U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot

Reuters
·
13 Nov 2024

Prime Medicine Inc : Chardan Capital Markets Cuts Target Price to $15 From $17

THOMSON REUTERS
·
13 Nov 2024

Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Nuvalent (NUVL)

TIPRANKS
·
13 Nov 2024

Prime Medicine, Inc. (PRME) Receives a Buy from TD Cowen

TIPRANKS
·
13 Nov 2024

Prime Medicine Q3 EPS $(0.44) Misses $(0.39) Estimate, Sales $209.00K

Benzinga
·
13 Nov 2024

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

THOMSON REUTERS
·
13 Nov 2024

Prime Medicine, Inc. Q3 EPS USD -0.44

THOMSON REUTERS
·
13 Nov 2024

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
13 Nov 2024

Prime Medicine treatment of retinal dystrophy granted orphan designation

TIPRANKS
·
26 Oct 2024